Scholars are divided on how to regulate heritable genome editing.<\/p>\n
Heritable genome editing refers to changing human reproductive cells so that the resulting fetus has genetic changes that its future offspring may inherit.<\/p>\n
Proponents of heritable gene-editing champion the possibility of editing out incurable heritable diseases, but others caution that gene editing may have unintended effects. For example, an edit to prevent a child from inheriting a disease might also reduce that childs immunity to other diseases, a concern that is amplified by the fact that any changes to immunity would be heritable.<\/p>\n
The debate is no longer theoretical. Shortly after reports of the first live births of gene-edited babies surfaced in 2018, a number of prominent scientists called for a ban on any further experimentation that would result in live births, at least until regulatory schemes were put in place.<\/p>\n
This weeks Saturday Seminar explores scholarly works on current and proposed regulatory approaches to heritable gene-editing, as well as the unique challenges to effective regulation given factors like the medical tourism industry.<\/p>\n
<\/p>\n
Read more: Scholars are divided on how to regulate heritable genome editing. Continue reading
\nThe Next Generation's Genes - The Regulatory Review<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"